- Home
- GNLX vs CGO Comparison
GNLX vs CGO Comparison
Compare GNLX & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- CGO
- Stock Information
- Founded
- GNLX 2001
- CGO 2004
- Country
- GNLX United States
- CGO United States
- Employees
- GNLX N/A
- CGO N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- GNLX Health Care
- CGO Finance
- Exchange
- GNLX Nasdaq
- CGO Nasdaq
- Market Cap
- GNLX 128.0M
- CGO 114.2M
- IPO Year
- GNLX 2023
- CGO N/A
- Fundamental
- Price
- GNLX $3.78
- CGO $11.75
- Analyst Decision
- GNLX Strong Buy
- CGO
- Analyst Count
- GNLX 5
- CGO 0
- Target Price
- GNLX $16.20
- CGO N/A
- AVG Volume (30 Days)
- GNLX 89.3K
- CGO 34.7K
- Earning Date
- GNLX 08-07-2025
- CGO 01-01-0001
- Dividend Yield
- GNLX N/A
- CGO 9.25%
- EPS Growth
- GNLX N/A
- CGO N/A
- EPS
- GNLX N/A
- CGO N/A
- Revenue
- GNLX N/A
- CGO N/A
- Revenue This Year
- GNLX N/A
- CGO N/A
- Revenue Next Year
- GNLX N/A
- CGO N/A
- P/E Ratio
- GNLX N/A
- CGO N/A
- Revenue Growth
- GNLX N/A
- CGO N/A
- 52 Week Low
- GNLX $1.95
- CGO $7.90
- 52 Week High
- GNLX $5.89
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- GNLX 62.02
- CGO 54.93
- Support Level
- GNLX $3.26
- CGO $11.50
- Resistance Level
- GNLX $3.50
- CGO $11.80
- Average True Range (ATR)
- GNLX 0.24
- CGO 0.15
- MACD
- GNLX 0.01
- CGO -0.01
- Stochastic Oscillator
- GNLX 99.47
- CGO 68.42
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.